HK1085646A1 - Antigenic compositions for immunization of non-human mammals against streptococcus equi - Google Patents

Antigenic compositions for immunization of non-human mammals against streptococcus equi

Info

Publication number
HK1085646A1
HK1085646A1 HK06101817.3A HK06101817A HK1085646A1 HK 1085646 A1 HK1085646 A1 HK 1085646A1 HK 06101817 A HK06101817 A HK 06101817A HK 1085646 A1 HK1085646 A1 HK 1085646A1
Authority
HK
Hong Kong
Prior art keywords
immunization
equi
human mammals
subsp
mammals against
Prior art date
Application number
HK06101817.3A
Other languages
English (en)
Inventor
Bengt Guss
Jan-Ingmar Flock
Karin Jacobsson
Kenneth Janzon
Lars Frykberg
Margareta Flock
Rune Bergman
Original Assignee
Intervacc Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervacc Ab filed Critical Intervacc Ab
Publication of HK1085646A1 publication Critical patent/HK1085646A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK06101817.3A 2002-10-11 2006-02-10 Antigenic compositions for immunization of non-human mammals against streptococcus equi HK1085646A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41766002P 2002-10-11 2002-10-11
PCT/SE2003/001587 WO2004032957A1 (en) 2002-10-11 2003-10-10 Immunization of non-human mammals against streptococcus equi

Publications (1)

Publication Number Publication Date
HK1085646A1 true HK1085646A1 (en) 2006-09-01

Family

ID=32094057

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06101817.3A HK1085646A1 (en) 2002-10-11 2006-02-10 Antigenic compositions for immunization of non-human mammals against streptococcus equi

Country Status (10)

Country Link
US (1) US8404245B2 (xx)
EP (1) EP1560594B1 (xx)
AT (1) ATE471156T1 (xx)
AU (1) AU2003269765B2 (xx)
CA (1) CA2501621C (xx)
DE (1) DE60333027D1 (xx)
DK (1) DK1560594T3 (xx)
HK (1) HK1085646A1 (xx)
NZ (1) NZ539255A (xx)
WO (1) WO2004032957A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US9023366B2 (en) * 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
EP2019687B1 (en) * 2006-03-29 2014-03-19 Merial Limited Vaccine against streptococci
CN102026658A (zh) * 2007-12-13 2011-04-20 英特瓦克公司 改进的免疫组合物
US20120225079A1 (en) * 2009-11-13 2012-09-06 Intervacc Ab Immunizing composition for reducing streptococcal infections
ES2612520T3 (es) 2010-05-26 2017-05-17 Intervacc Ab Vacuna contra infecciones estreptocócicas basada en proteínas recombinantes
WO2013043071A1 (en) * 2011-09-23 2013-03-28 Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa Modified albumin-binding domains and uses thereof to improve pharmacokinetics
CN114437235B (zh) * 2022-01-04 2024-02-09 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US5583014A (en) * 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
SE9003374D0 (sv) 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
SE9302855D0 (sv) 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
IES960488A2 (en) 1996-07-03 1997-11-19 Trinity College Dublin Subunit Vaccine for Streptococcus Equi
SE9804491D0 (sv) 1998-12-22 1998-12-22 Bengt Guss Novel fibronectin-binding protein

Also Published As

Publication number Publication date
CA2501621C (en) 2012-01-24
EP1560594A1 (en) 2005-08-10
DE60333027D1 (de) 2010-07-29
US20060140980A1 (en) 2006-06-29
ATE471156T1 (de) 2010-07-15
NZ539255A (en) 2007-12-21
DK1560594T3 (da) 2010-10-04
AU2003269765A1 (en) 2004-05-04
US8404245B2 (en) 2013-03-26
WO2004032957A1 (en) 2004-04-22
AU2003269765B2 (en) 2009-08-06
EP1560594B1 (en) 2010-06-16
CA2501621A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
HK1085646A1 (en) Antigenic compositions for immunization of non-human mammals against streptococcus equi
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
WO2003011223A3 (en) Immunomodulatory compounds and methods of use thereof
IL144671A0 (en) Immunological adjuvants compounds compositions and methods of use thereof
WO2005037190A3 (en) Multiplex vaccines
ATE513560T1 (de) Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird
PT2364724E (pt) Composição de vacina compreendendo um adjuvante de saponina
EP0831937A4 (en) IMMUNOLOGICAL COMBINATIONS AND RELATED METHODS
AU2003206532A1 (en) Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue
YU24004A (sh) Interleukin-12 kao adjuvant veterinarske vakcine
PL351894A1 (en) Novel compositions
WO2005028618A3 (en) Immunogenic compositions for streptococcus agalactiae
EA200700496A1 (ru) Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита
WO1999052548A3 (en) Conjugate vaccines for the prevention of dental caries
WO2002009752A3 (en) Immunological adjuvant compounds
WO2003083083A3 (en) Methods of using flt3-ligand in immunization protocols
WO2007052238A3 (en) Chimeric antigens and vaccines
WO2002004497A3 (en) Multiple antigenic peptides immunogenic against streptococcus pneumoniae
WO2002085409A3 (en) Methods and compositions for inducing an immune response to an antigen
WO2003040163A3 (en) Immunomodulating saponins, a method for their preparation and their use for vaccines

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161010